News | Clinical Decision Support | April 29, 2015

Gregg W. Stone Appointed to COR Medical Technologies' Senior Editorial Board

Columbia University Medical center physician, professor brings cardiovascular expertise to review of current medical research, conditions and treatments

April 29, 2015 — COR Medical Technologies (COR) announced that Gregg W. Stone, M.D. has been appointed to its Senior Editorial Board. 

Stone is a professor of medicine at Columbia University and the director of cardiovascular research and education for the Center for Interventional Vascular Therapy at the Columbia University Medical Center and New York Presbyterian Hospital in New York City. Stone also serves as the co-director of medical research and education at the Cardiovascular Research Foundation in New York. 

COR’s Senior Editorial Board provides input on current medical research, conditions and treatments. The board reviews conditions and best practice treatments in order to provide instant decision support from the most current, vetted information available to treat cardiovascular conditions.

“We are pleased to have Dr. Stone join the COR Senior Editorial Board,” said Vince Friedewald, M.D., COR founder and CEO.  “His cardiovascular and interventional vascular therapy experience adds great value to our team.”

Stone received his medical degree from the John Hopkins School of Medicine in Baltimore and completed his residency in internal medicine at the New York Hospital – Cornell Medical Center in New York City.  He trained in cardiology at Cedars-Sinai Medical Center in Los Angeles, and in advanced angioplasty at the Mid-America Heart Institute in Kansas City, Missouri. He is board certified by the American Board of Interventional Cardiology, American Board of Cardiovascular Diseases and American Board of Internal Medicine.

“I am honored to join the distinguished group of medical experts who sit on the COR Medical Technologies Senior Editorial Board,” said Stone. “I am excited to share my experience in cardiovascular medicine with the other members.”

COR Medical Technologies offers CORcare, a comprehensive instant decision support system for rapid and accurate diagnosis, treatment and follow-up management of patients with acute and chronic, common and rare diseases involving the cardiovascular system.

For more information: www.cormedtec.com

Related Content

Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Mobility May Predict Elderly Heart Attack Survivors' Repeat Hospital Stays
News | Cath Lab | April 23, 2019
Determining which elderly heart attack patients take longer to stand from a seated position and walk across a room may...
FDA Releases New Guidance on Medical Devices Containing Nitinol
News | Cath Lab | April 18, 2019
April 18, 2019 — The U.S.
Angiography shows a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL lithoplasty.

Figure 2: Angiography demonstrates a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification (double-headed arrow) in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL (inset; note the cavitation bubbles generated by IVL [black arrows]). (D) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-IVL and coregistered to the OCT lens (white arrow in C) demonstrate multiple calcium fractures and large acute luminal gain. (E) Angiography demonstrates complete stent expansion with the semicompliant stent balloon (inset) without the need for high-pressure noncompliant balloon inflation. (F) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-stenting and coregistered to the OCT lens (arrow in E) demonstrate further fracture displacement (arrow), with additional increase in the acute area gain (5.17 mm2), resulting in full stent expansion and minimal malapposition.

Feature | Cath Lab | April 15, 2019 | Dean Kereiakes, M.D., FACC, FSCAI, and Jonathan Hill, M.D., DISRUPT CAD III Co-Principal Investigators
Over the last 40 years, despite multiple advancements in percutaneous coronary interventions, calcified lesions remai
BIOTRONIK’s PK Papyrus covered coronary stent. The stent ius used in emergency coronary artery dissections to repair the vessel wall.
Technology | Cath Lab | April 15, 2019
April 15, 2019 — Biotronik began its U.S.
Providing Follow-Up Care After Heart Attack Helps Reduce Readmissions, Deaths
News | Cath Lab | April 09, 2019
A program designed to help heart attack patients with the transition from hospital to outpatient care can reduce...
TherOx Receives FDA Approval for SuperSaturated Oxygen Therapy
Technology | Cath Lab | April 08, 2019
TherOx Inc. announced that the U.S. Food and Drug Administration (FDA) granted premarket approval for its...
Cook Medical Recalls Transseptal Needle Due to Risk of Detached Plastic Fragments
News | Cath Lab | March 20, 2019
March 20, 2019 — Cook Medical is recalling one lot of its...
Overlay Init